Factors | N | I-VEGFR-3 | P-VEGFR-3 | ||
---|---|---|---|---|---|
 |  | N (%) | P | N (%) | P |
VEGF-A expression | Â | Â | 0.107 | Â | 0.067 |
   Low | 44 | 16(36.36) |  | 15(34.09) |  |
   High | 79 | 18(22.78) |  | 40(50.63) |  |
VEGF-C expression | Â | Â | 0.795 | Â | < 0.001 |
   Low | 42 | 11(26.19) |  | 9 (21.43) |  |
   High | 81 | 23(28.40) |  | 46(56.79) |  |
VEGF-D expression | Â | Â | 0.968 | Â | 0.043 |
   Low | 72 | 20(27.78) |  | 27(37.50) |  |
   High | 51 | 14(27.45) |  | 28(54.90) |  |
P-LVD | Â | Â | 0.813 | Â | <0.001 |
   <14 | 60 | 16(26.67) |  | 10(16.67) |  |
   ≥ 14 | 63 | 18(28.57) |  | 45(71.43) |  |
I-LVD | Â | Â | 0.412 | Â | 0.153 |
   <8 | 58 | 14(24.14) |  | 22(37.93) |  |
   ≥ 8 | 65 | 20(30.77) |  | 33(50.77) |  |
Lymph node metastasis | Â | Â | 0.934 | Â | 0.190 |
   Negative | 55 | 19(34.55) |  | 21(38.18) |  |
   Positive | 68 | 15(22.06) |  | 34(50.00) |  |
LVI | Â | Â | 0.681 | Â | 0.003 |
   Negative | 76 | 22(28.95) |  | 26(34.21) |  |
   Positive | 47 | 12(25.53) |  | 29(61.70) |  |
VI | Â | Â | 0.387 | Â | 0.448 |
   Negative | 87 | 26(29.89) |  | 37(42.53) |  |
   Positive | 36 | 8 (22.22) |  | 18(50.00) |  |